SCHEMBL8555645

SCHEMBL8555645

CC(c1cccc2c1C(=O)NC2=O)C1CNCCO1.O=C1NC(=O)c2c(CCBr)cccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.33
SLC6A4 P31645 11/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
MAPK10 P53779 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SLC6A3 Q01959 4/20 0.32
MLNR O43193 1/20 0.32
ADRB2 P07550 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2C P28335 1/20 0.32
OPRK1 P41145 1/20 0.32
KCNH2 Q12809 1/20 0.32
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8556232 0.89 SSTR4 (0.37) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8555647 0.80 KDM4E (0.36) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8558961 0.79 SLC6A2 (0.32) SLC6A2SLC6A4KDM4EALDH1A1SLC6A3
SCHEMBL28107993 0.77 PARP1 (0.40) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8557624 0.76 SLC6A2 (0.34) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8559529 0.75 SLC6A2 (0.34) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8554467 0.74 SLC6A2 (0.33) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8552813 0.74 SLC6A2 (0.33) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8553945 0.74 SLC6A2 (0.33) SLC6A2SLC6A4KDM4EALDH1A1HPGD
SCHEMBL8559643 0.74 SLC6A2 (0.33) SLC6A2SLC6A4KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575954-B1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI SRL (IT) 1998-09-02 EP disclosed